Substance / Medication

Edoxaban

Overview

Active Ingredient
edoxaban
RxNorm CUI
1599538

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Literature-based case analysis of serious adverse drug events associated with edoxaban.
Luan Xuanyu, Zhou Dongyang, Zhang Qingxia · Eur J Clin Pharmacol · 2025
PMID: 40483337Meta-Analysis
Effectiveness and safety of edoxabanwarfarin in patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies.
Alsultan Mohammed M, Alahmari Abdullah K, Mahmoud Mansour A et al. · Front Pharmacol · 2023
PMID: 38035002Meta-AnalysisFull text (PMC)
The Efficacy and Safety of Edoxaban for VTE Prophylaxis Post-Orthopedic Surgery: A Systematic Review.
AlHajri Lamia, Jabbari Sima, AlEmad Hind et al. · J Cardiovasc Pharmacol Ther · 2017
PMID: 27811198Meta-Analysis
Indirect comparison of dabigatran, rivaroxaban, apixaban and edoxaban for the treatment of acute venous thromboembolism.
Mantha Simon, Ansell Jack · J Thromb Thrombolysis · 2015
PMID: 24989022Meta-Analysis
Laboratory measurement of the anticoagulant activity of edoxaban: a systematic review.
Cuker Adam, Husseinzadeh Holleh · J Thromb Thrombolysis · 2015
PMID: 25669624Meta-AnalysisFull text (PMC)
Efficacy and Safety of Edoxaban in Nonvalvular Atrial Fibrillation: A Meta-analysis of Randomized Controlled Trials.
Chen Junyu, Zhuang Xiaodong, Long Ming et al. · J Stroke Cerebrovasc Dis · 2015
PMID: 26324517Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Edoxaban (substance)
SNOMED CT
712778008
UMLS CUI
C2975435
RxNorm CUI
1599538

Clinical Data

This intervention maps to 2 entities in the Healos knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.